# Virtual screening, molecular dynamics simulations, and in vitro analysis of Sophora flavescens-derived aloperine against Haemonchus contortus

**Authors:** Anben Li, Yan Ma, Wenxi Li, Bintao Zhai, Nana Fu, Jun Li, Qianyu Zhou, Yang Liu

PMC · DOI: 10.3389/fvets.2025.1620324 · Frontiers in Veterinary Science · 2025-06-19

## TL;DR

This study explores aloperine, a natural compound, as a potential treatment for Haemonchus contortus, a parasite resistant to ivermectin, showing promising results in lab tests.

## Contribution

The study introduces aloperine as a novel anthelmintic and Pgp inhibitor with synergistic effects when combined with ivermectin.

## Key findings

- Aloperine showed strong binding affinity and stable interaction with HC-Pgp.
- Combined ALO and IVM treatment significantly inhibited resistant H. contortus strains.
- Aloperine inhibited HC-Pgp activity, as shown by Rhodamine-123 accumulation assay.

## Abstract

The resistance of Haemonchus contortus to ivermectin (IVM) poses a significant economic threat to the global livestock industry. This necessitates alternative strategies for managing the development of drug resistance in H. contortus.

This study employed molecular docking screening, molecular dynamics simulations, and in vitro experiments to evaluate the effects of bioactive alkaloids from Sophora alopecuroides L. on H. contortus.

Molecular docking and dynamics simulations revealed aloperine (ALO)’s strong binding affinity (−6.83 kcal/mol) and stable interaction with HC-Pgp among 13 tested alkaloids. Further evaluation through larval development test (LDT), larval migration inhibition test (LMIT), and scanning electron microscopy revealed that the combined administration of ALO and IVM exerted significantly enhanced inhibitory effects on the development, motility, and morphological integrity of IVM-resistant strains compared to monotherapy groups. Furthermore, the Rhodamine-123 accumulation assay demonstrated that aloperine significantly inhibited HC-Pgp activity (p < 0.05).

This study provides new perspectives for exploring the natural product ALO as an anthelmintic, HC-Pgp inhibitor, and synergist molecule. Further studies evaluating in vivo safety and pharmacokinetic interactions are required to validate these findings.

## Linked entities

- **Chemicals:** aloperine (PubChem CID 162147), Rhodamine-123 (PubChem CID 65217)
- **Species:** Haemonchus contortus (taxon 6289)

## Full-text entities

- **Chemicals:** IVM (MESH:D007559), ALO (MESH:C062701), Rhodamine-123 (MESH:D020112), alkaloids (MESH:D000470)
- **Species:** Sophora flavescens (species) [taxon 49840], Sophora alopecuroides (species) [taxon 200492], Haemonchus contortus (barber pole worm, species) [taxon 6289]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12221915/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12221915/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12221915/full.md

---
Source: https://tomesphere.com/paper/PMC12221915